| Source: |
| Type: |
| Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors. |
| 6146- | Citrate, | Citric acid promotes SPARC release in pancreatic cancer cells and inhibits the progression of pancreatic tumors in mice on a high‐fat diet |
| - | in-vitro, | PC, | NA |
| 1583- | Citrate, | Extracellular citrate and metabolic adaptations of cancer cells |
| - | Review, | NA, | NA |
| 1580- | Citrate, | Citrate activates autophagic death of prostate cancer cells via downregulation CaMKII/AKT/mTOR pathway |
| - | in-vitro, | Pca, | PC3 | - | in-vivo, | PC, | NA | - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | WPMY-1 |
| 1579- | Citrate, | Effect of Food Additive Citric Acid on The Growth of Human Esophageal Carcinoma Cell Line EC109 |
| - | in-vitro, | ESCC, | Eca109 |
| 1578- | Citrate, | Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update |
| - | Review, | Var, | NA |
| 1577- | Citrate, | Citric acid promotes SPARC release in pancreatic cancer cells and inhibits the progression of pancreatic tumors in mice on a high-fat diet |
| - | in-vivo, | PC, | NA | - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | PATU-8988 | - | in-vitro, | PC, | MIA PaCa-2 |
| 4762- | CoQ10, | The role of coenzyme Q10 as a preventive and therapeutic agent for the treatment of cancers |
| - | Review, | Var, | NA |
| 4772- | CoQ10, | The anti-tumor activities of coenzyme Q0 through ROS-mediated autophagic cell death in human triple-negative breast cells |
| - | in-vitro, | BC, | MDA-MB-468 | - | in-vitro, | BC, | MDA-MB-231 |
| 6372- | CPLE, | Anti-proliferation and Apoptosis Induction of Aqueous Leaf Extract of Carica papaya L. on Human Breast Cancer Cells MCF-7 |
| - | in-vitro, | BC, | MCF7 |
| 6373- | CPLE, | Anticancer Activity of Phytochemicals of the Papaya Plant Assessed: A Narrative Review |
| - | Review, | Var, | NA |
| 5810- | CPT, | CPT-11, | Camptothein-Based Anti-Cancer Therapies and Strategies to Improve Their Therapeutic Index |
| - | Review, | NA, | NA |
| 6179- | Cro, | Crocetin suppresses the growth and migration in HCT-116 human colorectal cancer cells by activating the p-38 MAPK signaling pathway |
| - | NA, | CRC, | HCT116 |
| 6178- | Cro, | Exploring the therapeutic efficacy of crocetin in oncology: an evidence-based review |
| - | Review, | Var, | NA |
| 6291- | Cro, | Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model |
| - | vitro+vivo, | PC, | MIA PaCa-2 | - | vitro+vivo, | PC, | Bxpc-3 | - | vitro+vivo, | PC, | Capan1 | - | vitro+vivo, | PC, | AsPC-1 |
| 6314- | Cro, | Crocin promotes ferroptosis in gastric cancer via the Nrf2/GGTLC2 pathway |
| - | in-vitro, | GC, | NA |
| 6309- | Cro, | Crocin exerts anti-tumor effect in colon cancer cells via repressing the JaK pathway |
| - | in-vitro, | CRC, | HCT116 |
| 6308- | Cro, | Dietary Crocin is Protective in Pancreatic Cancer while Reducing Radiation-Induced Hepatic Oxidative Damage |
| - | vitro+vivo, | PC, | Bxpc-3 |
| 6306- | Cro, | Crocetin induces apoptosis of BGC-823 human gastric cancer cells |
| - | in-vitro, | GC, | BGC-823 |
| 6304- | Cro, | Crocin attenuates NF-κB-mediated inflammation and proliferation in breast cancer cells by down-regulating PRKCQ |
| - | in-vitro, | BC, | NA |
| 6294- | Cro, | Crocetin and Crocin from Saffron in Cancer Chemotherapy and Chemoprevention |
| - | Review, | Var, | NA |
| 6293- | Cro, | Crocetin: an agent derived from saffron for prevention and therapy for cancer |
| - | Review, | Var, | NA |
| 6292- | Cro, | Crocetin induces cytotoxicity and enhances vincristine-induced cancer cell death via p53-dependent and -independent mechanisms |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Lung, | A549 | - | in-vitro, | Ovarian, | SKOV3 |
| 6521- | CRV, | L-carvone induces p53, caspase 3 mediated apoptosis and inhibits the migration of breast cancer cell lines |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF10 |
| 6520- | CRV, | Health Benefits and Pharmacological Properties of Carvone |
| - | Review, | Nor, | NA |
| 6523- | CRV, | Anticancer effects of Carvone in myeloma cells is mediated through the inhibition of p38 MAPK signalling pathway, apoptosis induction and inhibition of cell invasion |
| - | NA, | Melanoma, | NA |
| 6526- | CRV, | Multi-targeted effects of D-carvone against Non-Small Cell Lung Cancer (NSCLC): A network pharmacology-based study |
| - | Review, | NSCLC, | NA |
| 6528- | CRV, | D-carvone inhibits growth, migration, cell cycle at G0/G1 phase and induces apoptosis in A431 cells by disrupting mitochondrial membrane potential |
| - | in-vitro, | Melanoma, | A431 |
| 6530- | CRV, | Monoterpenes as Anticancer Therapeutic Agents |
| - | Review, | Var, | NA |
| 7425- | CS, | Artichoke as a melanoma growth inhibitor |
| - | in-vitro, | Melanoma, | NA |
| 7412- | CS, | Chemo, | Artichoke Polyphenols Sensitize Human Breast Cancer Cells to Chemotherapeutic Drugs via a ROS-Mediated Downregulation of Flap Endonuclease 1 |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 6182- | Cu, | Role of cuproptosis in digestive system tumors (Review) |
| - | Review, | Var, | NA |
| 6189- | Cuc, | Cucurbitacin B inhibits proliferation and induces apoptosis via STAT3 pathway inhibition in A549 lung cancer cells |
| - | in-vitro, | Lung, | A549 |
| 6192- | Cuc, | Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway |
| - | vitro+vivo, | CRC, | NA |
| 6193- | Cuc, | Cucurbitacin E Inhibits Huh7 Hepatoma Carcinoma Cell Proliferation and Metastasis via Suppressing MAPKs and JAK/STAT3 Pathways |
| - | in-vitro, | Liver, | HUH7 |
| 6185- | Cuc, | Cucurbitacin B: A review of its pharmacology, toxicity, and pharmacokinetics |
| - | Review, | Var, | NA | - | Review, | Arthritis, | NA | - | Review, | AD, | NA |
| 6201- | Cuc, | Cucurbitacin B and Its Derivatives: A Review of Progress in Biological Activities |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6204- | Cuc, | Preliminary investigation of the anti-colon cancer activity of cucurbitacin C from cucumber: A network pharmacological study and experimental validation |
| - | in-vitro, | Colon, | HCT116 |
| 1505- | CUR, | Epigenetic targets of bioactive dietary components for cancer prevention and therapy |
| - | Review, | NA, | NA |
| 6229- | CUR, | Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells |
| - | in-vitro, | Cerv, | NA |
| 6223- | CUR, | Curcumin Rewires the Tumor Metabolic Landscape: Mechanisms and Clinical Prospects |
| - | Review, | Var, | NA |
| 872- | CUR, | RES, | New Insights into Curcumin- and Resveratrol-Mediated Anti-Cancer Effects |
| - | in-vitro, | BC, | TUBO | - | in-vitro, | BC, | SALTO |
| 1006- | CUR, | The effect of Curcuma longa extract and its active component (curcumin) on gene expression profiles of lipid metabolism pathway in liver cancer cell line (HepG2) |
| - | in-vitro, | Liver, | HepG2 |
| 472- | CUR, | Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis |
| - | vitro+vivo, | Ovarian, | SKOV3 | - | vitro+vivo, | Ovarian, | A2780S |
| 467- | CUR, | Curcumin inhibits liver cancer by inhibiting DAMP molecule HSP70 and TLR4 signaling |
| - | in-vitro, | Liver, | HepG2 |
| 479- | CUR, | Curcumin Has Anti-Proliferative and Pro-Apoptotic Effects on Tongue Cancer in vitro: A Study with Bioinformatics Analysis and in vitro Experiments |
| - | in-vitro, | Tong, | CAL27 |
| 461- | CUR, | Curcumin inhibits prostate cancer progression by regulating the miR-30a-5p/PCLAF axis |
| - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | DU145 |
| 458- | CUR, | Curcumin suppresses gastric cancer by inhibiting gastrin‐mediated acid secretion |
| - | vitro+vivo, | GC, | SGC-7901 |
| 404- | CUR, | Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy |
| - | vitro+vivo, | Lung, | A549 | - | vitro+vivo, | Lung, | H1299 |
| 477- | CUR, | Curcumin induces G2/M arrest and triggers autophagy, ROS generation and cell senescence in cervical cancer cells |
| - | in-vitro, | Cerv, | SiHa |
| 483- | CUR, | PDT, | Visible light and/or UVA offer a strong amplification of the anti-tumor effect of curcumin |
| - | in-vivo, | NA, | A431 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:327 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid